We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
How the MHRA makes decisions on what is a medicinal product (borderline products).
Check the tariff classification for a defined daily dose of active substances.
When to tell DVLA about a medical condition or disability - what will happen to your licence, renewing or reapplying for your licence.
Inflammation or ulceration of the mucous membrane of the upper respiratory passages or mouth by dust, liquid, or vapour: IIAC report.
Pharmacy, prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.
How to spot contagious equine metritis, what to do if you suspect it and measures to prevent its spread.
Information from the National Health Service on conditions, treatments, local services and healthy living
The symptoms and epidemiology of botulism.
A to Z on content relating to infectious diseases.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine etrasimod (Velsipity) to treat people with moderately to severely active ulcerative colitis.
Notifications of infectious diseases (NOIDs) and reportable causative organisms: legal duties of laboratories and medical practitioners.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
Industrial Injuries Disablement Benefit is help if you're ill or disabled from an accident or disease caused by work - eligibility, how to claim.
A review of diseases with multiple known causes and rebuttal in the industrial injuries scheme.
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
Patients with severe alopecia areata (patchy hair loss) could access a new medicine to help treat their condition.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).